Showing results (501-510 of 565) with videos related to

Sort By:
Pageof 57
The Oncologist|July 28, 2019
A Pilot Study of Sirolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTENTakefumi Komiya, Gideon M Blumenthal, Roopa DeChowdhury, et al.
Ecology Letters|October 16, 2012
Poised to prosper? A cross-system comparison of climate change effects on native and non-native species performanceCascade J B Sorte, Ines Ibáñez, Dana M Blumenthal, et al.
JAMA Cardiology|May 26, 2018
A Survey of Interventional Cardiologists' Attitudes and Beliefs About Public Reporting of Percutaneous Coronary InterventionDaniel M Blumenthal, Linda R Valsdottir, Yuansong Zhao, et al.
Human Immunology|August 10, 1999
Determination of Duffy genotypes in three populations of African descent using PCR and sequence-specific oligonucleotidesR G Nickel, S A Willadsen, L R Freidhoff, et al.
Molecular Ecology|November 6, 2009
Turtle groups or turtle soup: dispersal patterns of hawksbill turtles in the CaribbeanJ M Blumenthal, F A Abreu-Grobois, T J Austin, et al.
Journal of Bacteriology|January 1, 1996
Host-mediated modification of PvuII restriction in Mycobacterium tuberculosisD van Soolingen, P E de Haas, R M Blumenthal, et al.
Nature Communications|August 24, 2016
Global threats from invasive alien species in the twenty-first century and national response capacitiesRegan Early, Bethany A Bradley, Jeffrey S Dukes, et al.
Ecological Applications : a Publication of the Ecological Society of America|February 22, 2023
Combining local, landscape, and regional geographies to assess plant community vulnerability to invasion impactInés Ibáñez, Laís Petri, David T Barnett, et al.
The Oncologist|December 16, 2017
FDA Benefit-Risk Assessment of Osimertinib for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M MutationLauretta Odogwu, Luckson Mathieu, Kirsten B Goldberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2016
FDA Approval: Alectinib for the Treatment of Metastatic, ALK-Positive Non-Small Cell Lung Cancer Following CrizotinibErin Larkins, Gideon M Blumenthal, Huanyu Chen, et al.
Pageof 57